PUBLIC SECTOR PENSION INVESTMENT BOARD - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 244 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2019. The put-call ratio across all filers is 8.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUBLIC SECTOR PENSION INVESTMENT BOARD ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2023$585,766
-27.6%
79,696
+2.1%
0.00%
-33.3%
Q1 2023$809,012
-15.8%
78,090
-4.0%
0.01%
-14.3%
Q4 2022$960,673
+56178.4%
81,3440.0%0.01%
-50.0%
Q3 2022$1,707
-99.9%
81,344
-1.7%
0.01%
-36.4%
Q2 2022$2,569,000
-30.0%
82,778
-7.4%
0.02%0.0%
Q1 2022$3,670,000
-13.4%
89,370
-8.4%
0.02%
-4.3%
Q4 2021$4,239,000
+1100.8%
97,520
+1640.5%
0.02%
+1050.0%
Q2 2021$353,000
-3.8%
5,603
+41.9%
0.00%0.0%
Q1 2021$367,000
+8.9%
3,948
+5.1%
0.00%
-33.3%
Q4 2020$337,000
-95.7%
3,757
-96.2%
0.00%
-95.9%
Q2 2020$7,876,000
+38.5%
99,599
+1.3%
0.07%
+10.6%
Q1 2020$5,688,000
+7.3%
98,2990.0%0.07%
+100.0%
Q4 2019$5,303,000
-8.9%
98,299
-11.7%
0.03%
-15.4%
Q3 2019$5,819,000
+20.7%
111,299
+11.5%
0.04%0.0%
Q2 2019$4,820,000
+131.7%
99,779
+142.3%
0.04%
+105.3%
Q1 2019$2,080,000
-43.4%
41,179
-33.6%
0.02%
-38.7%
Q4 2018$3,675,000
+83.2%
61,989
+103.4%
0.03%
+121.4%
Q3 2018$2,006,000
-19.0%
30,479
-37.9%
0.01%
-17.6%
Q2 2018$2,478,000
-4.1%
49,0770.0%0.02%
-5.6%
Q1 2018$2,584,000
+154.1%
49,077
+124.3%
0.02%
+157.1%
Q4 2017$1,017,000
+14.9%
21,8770.0%0.01%
+75.0%
Q3 2017$885,000
+46.8%
21,877
+23.0%
0.00%
-20.0%
Q2 2017$603,000
-14.5%
17,781
-26.8%
0.01%
-16.7%
Q1 2017$705,000
-11.5%
24,2810.0%0.01%
-25.0%
Q4 2016$797,000
+4.0%
24,2810.0%0.01%0.0%
Q3 2016$766,000
+25.6%
24,281
+12.0%
0.01%
+14.3%
Q2 2016$610,000
-22.6%
21,6810.0%0.01%
-22.2%
Q1 2016$788,000
-5.6%
21,681
+3.8%
0.01%
+28.6%
Q4 2015$835,000
-11.9%
20,881
-37.3%
0.01%
-12.5%
Q3 2015$948,000
-37.4%
33,281
-27.6%
0.01%
-27.3%
Q2 2015$1,515,000
-5.7%
45,981
-17.7%
0.01%
-8.3%
Q1 2015$1,607,000
+7.6%
55,881
+1.9%
0.01%
+20.0%
Q4 2014$1,493,000
+27.8%
54,8230.0%0.01%
+25.0%
Q3 2014$1,168,000
-19.9%
54,823
-15.6%
0.01%
-11.1%
Q2 2014$1,458,000
-1.7%
64,923
+10.6%
0.01%0.0%
Q1 2014$1,483,000
-7.8%
58,684
-16.1%
0.01%
-10.0%
Q4 2013$1,609,000
+22.5%
69,984
+1.4%
0.01%
+25.0%
Q3 2013$1,314,000
+86.9%
68,984
+41.4%
0.01%
+60.0%
Q2 2013$703,00048,7840.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders